Insider Transactions in Q4 2023 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103
+1.3%
|
-
|
|
Dec 31
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+20.0%
|
-
|
|
Dec 31
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+20.0%
|
-
|
|
Dec 15
2023
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
2,009
-11.62%
|
$608,727
$303.0 P/Share
|
|
Dec 14
2023
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
10,391
-37.54%
|
$3,158,864
$304.15 P/Share
|
|
Dec 01
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,039
-0.43%
|
$6,562,647
$273.26 P/Share
|
|
Dec 01
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
24,039
-0.43%
|
$6,562,647
$273.26 P/Share
|
|
Nov 30
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,871
-0.14%
|
$2,140,912
$272.18 P/Share
|
|
Nov 30
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
7,871
-0.14%
|
$2,140,912
$272.18 P/Share
|
|
Nov 29
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,257
-0.19%
|
$5,781,904
$272.74 P/Share
|
|
Nov 29
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
21,257
-0.19%
|
$5,781,904
$272.74 P/Share
|
|
Nov 28
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
21,833
-0.39%
|
$5,960,409
$273.66 P/Share
|
|
Nov 28
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,833
-0.39%
|
$5,960,409
$273.66 P/Share
|
|
Nov 27
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,900,000
$276.1 P/Share
|
|
Nov 27
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,900,000
$276.1 P/Share
|
|
Nov 22
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,925,000
$277.81 P/Share
|
|
Nov 22
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,925,000
$277.81 P/Share
|
|
Nov 21
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,925,000
$277.37 P/Share
|
|
Nov 21
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,925,000
$277.37 P/Share
|
|
Nov 20
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.86%
|
$13,750,000
$275.45 P/Share
|
|
Nov 20
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.86%
|
$13,750,000
$275.45 P/Share
|
|
Nov 17
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.86%
|
$13,650,000
$273.91 P/Share
|
|
Nov 17
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.86%
|
$13,650,000
$273.91 P/Share
|
|
Nov 16
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,000
-0.29%
|
$4,777,000
$281.61 P/Share
|
|
Nov 16
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,000
-0.29%
|
$4,777,000
$281.61 P/Share
|
|
Nov 15
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,000
-0.56%
|
$9,339,000
$283.42 P/Share
|
|
Nov 15
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
33,000
-0.56%
|
$9,339,000
$283.42 P/Share
|
|
Nov 14
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.42%
|
$7,075,000
$283.11 P/Share
|
|
Nov 14
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.42%
|
$7,075,000
$283.11 P/Share
|
|
Oct 23
2023
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+21.32%
|
$240,000
$32.05 P/Share
|